Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

500 seniors join 5-Year quest to unlock secrets of healthy aging

NCT ID NCT07180147

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

The ALOHA study is a community-based research project for adults aged 50 and older in the Washington, D.C., Maryland, and Virginia area. Over five years, participants receive annual health assessments—including physical and cognitive tests—and get a personalized 'Health Passport' with tailored recommendations. The goal is to track changes in health and understand how these recommendations affect independence, mobility, and brain health.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 500 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2025

Expected to finish

Jul 2031

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Community-dwelling adults aged 50 years and older living in the Washington, D.C., Maryland, and Virginia metropolitan area. Participants are generally healthy or have manageable chronic conditions and are able to complete physical, cognitive, and psychosocial assessments. Recruitment will emphasize diversity, including racial/ethnic minority groups and individuals from underserved communities, with study materials available in English and Spanish.

Ages

50 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 50 years or older at time of enrollment * Residing in the Washington, District of Columbia (DC)., Maryland, or Virginia metropolitan areas * Community-dwelling (living independently or with minimal assistance) * Able to participate in physical and cognitive assessments * Able to provide informed consent * Willing to return for annual follow-up assessments for up to 5 years Exclusion Criteria: * Diagnosis of dementia or significant cognitive impairment that prevents informed consent or participation in assessments * Severe physical disability or medical condition that precludes participation in study assessments (e.g., unstable cardiac condition, severe mobility limitation) * Current diagnosis of a terminal illness with life expectancy less than 12 months * Residing in a long-term care facility or nursing home at time of enrollment * Inability to communicate in English or Spanish (study materials available in these languages only) * Participation in another interventional trial that could confound study results

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Alzheimer disease (AD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Center for Optimal Aging, Marymount University

    Arlington, Virginia, 22201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.